Viewing Study NCT02279095


Ignite Creation Date: 2025-12-24 @ 2:09 PM
Ignite Modification Date: 2026-06-01 @ 12:20 PM
Study NCT ID: NCT02279095
Status: COMPLETED
Last Update Posted: 2025-02-19
First Post: 2014-10-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-Label Extension Study of Palovarotene Treatment in Fibrodysplasia Ossificans Progressiva (FOP)
Sponsor: Clementia Pharmaceuticals Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: PVO-1A-202
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators